TICKERNERD
Menu
AMTXAMTXBasic Materials · Specialty Chemicals

AMTX Stock Forecast: Aemetis, Inc. Price Predictions for 2026-2027

Last close, 7 Oct 2026
$1.75
−2.23% on the day

The 4 Wall Street analysts covering Aemetis, Inc. hold a median 12-month price target of $12 — +557.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 50 of 100 as at 6 Oct 2026 — in the upper half.

Market cap
$129.2M
Ticker Nerd rank
50 / 100
Median analyst target
$12
Analysts covering
4
Revenue$62.7M+20.0% y/y
Operating income$5.8M
Net income−$9.4M
Free cash flow−$10.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.7%
1M
−4.4%
YTD
+25.9%
1Y
−41.7%
From 52W high
−52.2%
From 52W low
+32.6%
$1.32
$3.66
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AMTX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Aemetis, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 6 Oct 2026
50 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
95
Revisions
74
Size
73
Accruals
54
Volatility
45
Quality
40
Value
32
Momentum
29
Issuance
8

Growth (95): Sales and profits are climbing, and climbing faster than before.

Issuance (8): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AMTX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AMTX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$−5.00$0.00$5.00$10.00$15.00$20.00$25.00$30.00Jan 26Apr 26Jul 26Oct 26AMTXHigh $28Median $12Low $3

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says4 analysts
3 Buy1 Hold0 Sell
Low $3Median $12High $28

The green dot is the last close — the median target sits +557.1% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
20 Aug 2026Ascendiant CapitalMaintainsBuy$22 → $20
22 May 2026Ascendiant CapitalMaintainsBuy$21 → $22
22 May 2026Ascendiant CapitalMaintainsBuy—
8 Apr 2026Ascendiant CapitalMaintainsBuy—
19 Nov 2025Ascendiant CapitalMaintainsBuy—
6 Oct 2025Ascendiant CapitalMaintainsBuy—
30 June 2025UBSMaintainsBuy—
6 June 2025Ascendiant CapitalMaintainsBuy—
9 May 2025UBSMaintainsBuy—
17 Mar 2025Ascendiant CapitalMaintainsBuy—
14 Mar 2025HC Wainwright & Co.ReiteratesBuy—
23 Dec 2024HC Wainwright & Co.ReiteratesBuy—
15 Nov 2024HC Wainwright & Co.ReiteratesBuy—
3 Sept 2024Ascendiant CapitalMaintainsBuy—
19 Aug 2024UBSMaintainsBuy—
2 Aug 2024HC Wainwright & Co.ReiteratesBuy—
31 July 2024Truist SecuritiesReiteratesHold—
13 May 2024Truist SecuritiesReiteratesHold—
10 May 2024HC Wainwright & Co.ReiteratesBuy—
8 Mar 2024HC Wainwright & Co.ReiteratesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMTX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

AMTX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 7 Oct 2026, Aemetis, Inc. returned −41.7% against +17.4% for the S&P 500, dividends included.

AMTX vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26AMTXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AMTX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Aemetis, Inc. (AMTX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.4×

Cheaper than 84% of US stocks

Price / sales
0.6×

Cheaper than 80% of US stocks

Price / book
−0.4×

Cheaper than 93% of US stocks

EV / EBITDA
−431.4×

Cheaper than 99% of US stocks

Growth & margins
Revenue growth (YoY)
20.0%

Higher than 69% of US stocks

Earnings growth (YoY)
20.0%

Higher than 58% of US stocks

Gross margin
21.6%

Higher than 23% of US stocks

Operating margin
9.2%

Higher than 63% of US stocks

Net margin
−26.1%

Higher than 14% of US stocks

Returns & dividend
Return on equity
25.1%

Higher than 85% of US stocks

Return on assets
−2.7%

Higher than 35% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Aemetis, Inc. (AMTX) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Aemetis, Inc. has a market value of $129.2M and an enterprise value of $680.3M.

  • Revenue in the twelve months to 30 June 2026: $230.2M. The latest quarter grew 20.0% year on year.

  • Net income over the same four quarters: −$60.2M, a −26.1% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.91.

  • Free cash flow in the twelve months to 30 June 2026: −$39.3M, after $35.7M of capital spending.

  • Shares outstanding: 72.0M.

  • Trailing P/E: −1.4×; forward P/E: −3.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Aemetis, Inc. employs 220 people — $1.0M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 7 Oct 2026

Data provided by Twelve Data

Peers

AMTX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
AMTXAemetis, Inc.$129.2M
50
ACNTAscent Industries Co.$124.9M
52
FEAM5E Advanced Materials, Inc.$156.1M
35
FSIFlexible Solutions International, Inc.$80.3M
19
CMTCore Molding Technologies, Inc.$201.4M
34
NTICNorthern Technologies International Corp.$74.1M
47
FFFutureFuel Corp.$226.0M
39

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Aemetis, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AMTX news & analysis

3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI

Schaeffers Research · 28 Sept 2026negative

Options bears are circling Aemetis Inc (AMTX), along with Acadia Pharmaceuticals and Resideo Technologies, with puts handily outpacing calls in today's trading. The article highlights that put traders are targeting these three stocks.

Why it matters — Increased put activity suggests bearish sentiment among options traders regarding AMTX, which may signal market expectations for potential downside moves.

Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits

GlobeNewsWire · 28 Sept 2026positive

Aemetis, Inc. announced that it received $22.4 million from the sale of Section 45Z Clean Fuel Production Tax Credits. The payment was disclosed in a company news release dated September 28, 2026.

Why it matters — The cash inflow from monetizing clean fuel production tax credits provides Aemetis with additional liquidity, which is relevant for a watcher monitoring the company's financial position.

Stonegate Capital Partners Updates Coverage on Aemetis Inc. (AMTX) 2Q26

Newsfile Corp · 10 Aug 2026positive

Stonegate Capital Partners updated its coverage of Aemetis Inc. following the company's 2Q26 results. Aemetis reported positive operating income driven by quarterly 45Z credit recognition, higher renewable natural gas production, and improved ethanol economics, which made the operating inflection visible.

Why it matters — This analyst update highlights that Aemetis' quarterly results turned to positive operating income, a milestone that AMTX watchers would track as evidence of improved financial performance.

Aemetis, Inc. (AMTX) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

Seeking Alpha published a transcript of Aemetis, Inc.'s (AMTX) Q2 2026 earnings call. The item announces the availability of the full earnings call transcript for the company's second-quarter 2026 results.

Why it matters — An AMTX watcher would care because the earnings call transcript provides management's discussion of the company's latest quarterly performance and outlook.

Aemetis Q2 Earnings Call Highlights

MarketBeat · 6 Aug 2026positive

Aemetis reported higher second-quarter revenue and a return to operating profitability, citing growth in its California ethanol and dairy renewable natural gas businesses along with contributions from federal Section 45Z production tax credits.

Why it matters — The move to operating profitability and higher revenue reflects strengthening performance in the company's core ethanol and renewable natural gas segments.

FAQ

Frequently asked questions about AMTX stock

What is the AMTX stock price forecast for 2026-2027?

The 4 Wall Street analysts covering Aemetis, Inc. have a median 12-month price target of $12, with estimates ranging from $2.5 to $28. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AMTX stock a buy right now?

Of the 4 analysts covering Aemetis, Inc., 3 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Aemetis, Inc. 50 out of 100 across roughly 4,600 US stocks as at 6 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AMTX?

As at 6 Oct 2026, Aemetis, Inc. ranks 50 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (95 of 100).

Will AMTX stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +557.1% from the last close, and Ticker Nerd's factor model ranks Aemetis, Inc. 50 out of 100 as at 6 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AMTX stock forecast for 2030?

No analyst covering Aemetis, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMTX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2.5 to $28 over the next 12 months.

How has AMTX stock performed over the past year?

Aemetis, Inc. returned -41.7% over the 12 months to 7 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Aemetis, Inc. do?

Aemetis Inc. is a renewable fuels and biochemicals company that develops and operates technologies designed to replace petroleum-based products with low- and negative-carbon alternatives.

What is the latest news on AMTX?

The most recent item we track (Schaeffers Research, 28 Sept 2026): "3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI". Options bears are circling Aemetis Inc (AMTX), along with Acadia Pharmaceuticals and Resideo Technologies, with puts handily outpacing calls in today's trading. The article highlights that put traders are targeting these three stocks.

Company

About Aemetis, Inc.

Aemetis Inc. is a renewable fuels and biochemicals company that develops and operates technologies designed to replace petroleum-based products with low- and negative-carbon alternatives. The company focuses on producing renewable natural gas, ethanol, biodiesel, and related co-products used in transportation fuel, agricultural feed, and industrial applications. Its current operations span North America and India, with business segments centered on California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Aemetis also works on biogas capture, carbon reduction solutions, and the commercialization of advanced fuel and chemical processes. Headquartered in Cupertino, California, Aemetis serves markets tied to decarbonization, low-carbon fuel standards, and renewable energy supply chains.

CEO Mr. Eric A. McAfee · 220 employees · United States · https://www.aemetis.com